News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Meta touted as tactical long due to vast behavioral data, strong cash flow and $1.7T market cap; entry $670, stop $600, target $780.
  • Netskope showing top-line acceleration and AI networking gains, earnings beat at 28% revenue growth; buy thesis entry $17.50, stop $14.
  • Pagaya reports accelerating ABS sales, double-digit revenue growth and positive free cash flow; tactical long target $30, stop $18.
  • McDonald's sold off with the sector despite durable fundamentals, $7.4B free cash flow and 2.96% yield; tactical long underway.
  • First Advantage faces execution risk after share sale and thin profitability; tactical short targets ~$16 with stop above $22.50.
  • Deutsche Bank survey shows investors remain cautious with low sentiment despite tight market ranges and modest large-cap overweight.
  • Intesa Sanpaolo recommended buy for income with 4%+ yield, strong efficiency and a large 2026 capital return plan.

Latest Articles

Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026

Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026

Relay Therapeutics announced it will report its second quarter 2026 financial results and corporate highlights on August 6, 2026. The clinical-stage precision medicine company is advancing small molecule therapies targeting cancer and genetic diseases, with a lead asset, zovegalisib, currently in Phase 3 trials for metastatic breast cancer and othe…

Exponent Reports Second Quarter 2026 Financial Results

Exponent Reports Second Quarter 2026 Financial Results

Exponent, Inc. reported robust financial results for Q2 2026, with total revenues rising 21% year-over-year to $171.6 million and net income increasing to $29.4 million. The growth was fueled by strong demand for user research related to AI-enabled products, infrastructure and risk management projects in utilities, and reactive work in consumer pro…

Stryker reports second quarter 2026 operating results

Stryker reports second quarter 2026 operating results

Stryker Corporation reported robust second quarter 2026 results, with net sales up 9.4% to $6.6 billion, organic net sales rising 9.0%, and adjusted EPS increasing 17.9% to $3.69. The company improved its operating income margin by 170 basis points to 27.4% adjusted and achieved reported EPS growth of 44.1%. Stryker narrowed its full-year 2026 outl…

The Cheesecake Factory Opens at The Collection at Forsyth

The Cheesecake Factory Opens at The Collection at Forsyth

CTO Realty Growth, Inc. announced the opening of The Cheesecake Factory at The Collection at Forsyth, enhancing the center's retail and dining offerings in a fast-growing Atlanta submarket. This addition has created over 200 local jobs, highlighting strong leasing demand and continued growth momentum within this premier lifestyle destination. Upcom…

LPL Financial Announces Second Quarter 2026 Results

LPL Financial Announces Second Quarter 2026 Results

LPL Financial Holdings Inc. announced robust second quarter 2026 results with net income up 39% year-over-year to $379 million, diluted EPS of $4.74, and adjusted EPS growth of 29%. Total client assets increased 34% to $2.6 trillion, driven by advisory asset growth of 46%. The company completed the acquisition of Mariner Advisor Network and is on t…

Cavco Industries Reports Fiscal 2027 First Quarter Results

Cavco Industries Reports Fiscal 2027 First Quarter Results

Cavco Industries reported a 9.5% increase in net revenue for the first quarter of fiscal 2027 driven by higher home sales volume and the acquisition of American Homestar. Despite record shipments and a backlog increased by over 50%, net income declined due to margin compression and higher operating expenses. Regulatory progress supports long-term g…

JFB and XTEND Provide Consolidated Update on Commercial and Transaction Momentum Ahead of Anticipated Third Quarter Closing of Business Combination

JFB and XTEND Provide Consolidated Update on Commercial and Transaction Momentum Ahead of Anticipated Third Quarter Closing of Business Combination

JFB Construction Holdings and XTEND provided a comprehensive update on significant defense contracts exceeding $27 million, advancement in the U.S. Drone Dominance Program, new U.S. patents, and ongoing transaction progress toward their anticipated third quarter 2026 business combination closing. XTEND is poised to deliver drone systems next week f…

Columbia Financial, Inc. Announces Q2 2026 Financial Results and Commences Quarterly Cash Dividend

Columbia Financial, Inc. Announces Q2 2026 Financial Results and Commences Quarterly Cash Dividend

Columbia Financial, Inc. announced solid second quarter 2026 financial results, with net income rising to $14.5 million, or $0.14 per share, up from $12.3 million the prior year. The quarter reflected higher net interest income driven by increased loan balances and decreased interest expense, alongside non-interest income gains. The company declare…

Veracyte Announces Second Quarter 2026 Financial Results

Veracyte Announces Second Quarter 2026 Financial Results

Veracyte, a cancer diagnostics company traded on Nasdaq (ticker: VCYT), announced its financial results for Q2 2026, highlighting a 15% increase in total revenue to $150.3 million and a 19% increase in testing revenue to $145.7 million driven by growth in key tests Decipher and Afirma. The company launched two new products — Prosigna LDT and TrueMR…

Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

Trevi Therapeutics, a clinical-stage biopharmaceutical company focused on developing Haduvio™ (oral nalbuphine ER) for chronic cough related to idiopathic pulmonary fibrosis, non-IPF interstitial lung disease, and refractory chronic cough, will announce its second quarter 2026 financial results and provide a corporate update on August 6, 2026. The …

SPX Reports Second Quarter 2026 Results

SPX Reports Second Quarter 2026 Results

SPX Technologies announced impressive second quarter 2026 results with significant year-over-year growth in revenue, GAAP income, and earnings per share. The company raised its full-year 2026 guidance, citing strong organic and inorganic growth, including the acquisition of Neptronic and increased data center capacity. Both HVAC and Detection & Mea…

SPS Commerce Reports Strong Second Quarter 2026 Financial Results

SPS Commerce Reports Strong Second Quarter 2026 Financial Results

SPS Commerce announced its second quarter 2026 financial results with revenue of $197.8 million, a 6% increase year-over-year, and a 19% rise in adjusted EBITDA reaching $66.6 million. The company exceeded the high end of its guidance range and revealed plans to launch its AI-powered MAX platform to all SPS Fulfillment customers later in the summer…

Aqua Metals Reports Second Quarter 2026 Results and Advances Phased Commercialization Plan for Headwaters ARC

Aqua Metals Reports Second Quarter 2026 Results and Advances Phased Commercialization Plan for Headwaters ARC

Aqua Metals reports Q2 2026 results and significant progress on its Headwaters ARC commercialization plan to develop battery recycling and critical minerals recovery infrastructure focused on LFP battery materials. The company is moving toward final site selection, equipment partner agreements, and capital formation to begin Phase 1 operations, whi…

BJ’s Restaurants, Inc. Reports Fiscal Second Quarter 2026 Results

BJ’s Restaurants, Inc. Reports Fiscal Second Quarter 2026 Results

BJ's Restaurants, Inc. announced fiscal Q2 2026 results with total revenues up 6.4%, a 6.5% increase in comparable restaurant sales, and improved restaurant level operating profit margin. The company also raised its full-year 2026 financial guidance, reflecting strong sales, traffic growth, and increased profitability. Share repurchases continued w…

Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability

Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability

Myriad Genetics reported Q2 2026 revenues of $190.7 million, an 11% decline year-over-year driven by a slight volume decrease and reduced revenue per test. The company launched new cancer diagnostics products and expanded test availability, particularly in the Cancer Care Continuum segment, while executing initiatives to improve reimbursement predi…